(EHTH) eHealth - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US28238P1093

Medicare, Individual-Family, Small Business, Dental, Vision

EHTH EPS (Earnings per Share)

EPS (Earnings per Share) of EHTH over the last years for every Quarter: "2020-03": 0.13, "2020-06": -0.13, "2020-09": -0.55, "2020-12": 2.2, "2021-03": -0.03, "2021-06": -0.69, "2021-09": -1.98, "2021-12": -1.19, "2022-03": -1.2, "2022-06": -1.65, "2022-09": -1.43, "2022-12": 0.75, "2023-03": -0.72, "2023-06": -0.84, "2023-09": -1.32, "2023-12": 1.78, "2024-03": -0.59, "2024-06": -0.96, "2024-09": -1.44, "2024-12": 3.19, "2025-03": 0.07,

EHTH Revenue

Revenue of EHTH over the last years for every Quarter: 2020-03: 106.408, 2020-06: 88.766, 2020-09: 94.284, 2020-12: 293.316, 2021-03: 134.214, 2021-06: 96.557, 2021-09: 63.914, 2021-12: 243.514, 2022-03: 105.25, 2022-06: 50.409, 2022-09: 53.376, 2022-12: 196.321, 2023-03: 73.723, 2023-06: 66.768, 2023-09: 64.718, 2023-12: 247.662, 2024-03: 92.964, 2024-06: 65.856, 2024-09: 58.409, 2024-12: 315.181, 2025-03: 113.119,

Description: EHTH eHealth

eHealth Inc (NASDAQ:EHTH) is a leading online health insurance marketplace that connects consumers with a vast array of health insurance plans from various carriers across the United States. The companys platform is designed to empower individuals, families, and small businesses to navigate the complex health insurance landscape, providing them with the tools and resources needed to make informed decisions about their health insurance coverage.

The companys business model is segmented into two primary categories: Medicare and Employer/Individual. The Medicare segment focuses on providing Medicare-related health insurance plans, including Medicare Advantage, Medicare Supplement, and Medicare Part D prescription drug plans, to Medicare-eligible customers. In contrast, the Employer and Individual segment caters to non-Medicare-eligible customers, offering individual, family, and small business health insurance plans, as well as ancillary products such as dental, vision, and short-term insurance.

eHealths ecommerce platforms and consumer engagement solutions are designed to provide a user-friendly experience, allowing customers to research, analyze, compare, and purchase health insurance plans that best suit their needs. The companys websites, including eHealth.com, eHealthInsurance.com, and Medicare.com, serve as a one-stop-shop for health insurance consumers, offering a wealth of information, decision-support tools, and transactional services. Additionally, eHealth generates revenue through online sponsorship and advertising, lead referrals, technology licensing, and post-enrollment services for members in Medicare health insurance plans.

From a technical analysis perspective, EHTHs stock price has been trending downward, with the short-term SMA20 and long-term SMA200 indicating a bearish outlook. However, the Average True Range (ATR) suggests that the stocks volatility is relatively high, presenting potential trading opportunities. Using the provided technical data, we can forecast that EHTHs stock price may continue to experience downward pressure in the short term, potentially testing the 52-week low of $3.60. Nevertheless, if the company can demonstrate strong fundamental growth, the stock price may eventually rebound.

From a fundamental analysis perspective, eHealths market capitalization stands at $138.93M, with a forward P/E ratio of 6.82, indicating that the stock may be undervalued relative to its growth prospects. The companys Return on Equity (RoE) is relatively low at 1.27, suggesting that eHealth may need to improve its profitability. Using the provided fundamental data, we can forecast that EHTHs stock price may experience a significant increase if the company can demonstrate strong revenue growth, improved profitability, and effective management of its operating expenses. A potential price target could be in the range of $8-10 per share, representing a 50-100% increase from the current price.

Additional Sources for EHTH Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

EHTH Stock Overview

Market Cap in USD 129m
Sector Financial Services
Industry Insurance Brokers
GiC Sub-Industry Insurance Brokers
IPO / Inception 2006-10-13

EHTH Stock Ratings

Growth Rating -68.2
Fundamental -8.84
Dividend Rating 0.0
Rel. Strength -27.3
Analysts 3.4 of 5
Fair Price Momentum 2.62 USD
Fair Price DCF -

EHTH Dividends

Currently no dividends paid

EHTH Growth Ratios

Growth Correlation 3m -90.7%
Growth Correlation 12m 28.6%
Growth Correlation 5y -80.6%
CAGR 5y -47.49%
CAGR/Max DD 5y -0.49
Sharpe Ratio 12m -0.82
Alpha -21.42
Beta 0.815
Volatility 73.58%
Current Volume 114.3k
Average Volume 20d 203k
What is the price of EHTH shares?
As of July 05, 2025, the stock is trading at USD 4.16 with a total of 114,338 shares traded.
Over the past week, the price has changed by -0.48%, over one month by -5.45%, over three months by -29.25% and over the past year by -5.45%.
Is eHealth a good stock to buy?
Neither. Based on ValueRay´s Fundamental Analyses, eHealth is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -8.84 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of EHTH is around 2.62 USD . This means that EHTH is currently overvalued and has a potential downside of -37.02%.
Is EHTH a buy, sell or hold?
eHealth has received a consensus analysts rating of 3.40. Therefor, it is recommend to hold EHTH.
  • Strong Buy: 1
  • Buy: 0
  • Hold: 4
  • Sell: 0
  • Strong Sell: 0
What are the forecasts for EHTH share price target?
According to our own proprietary Forecast Model, EHTH eHealth will be worth about 2.9 in July 2026. The stock is currently trading at 4.16. This means that the stock has a potential downside of -30.77%.
Issuer Target Up/Down from current
Wallstreet Target Price 10 140.4%
Analysts Target Price 10 140.4%
ValueRay Target Price 2.9 -30.8%